|
1
|
Tore LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bertuccio P, Chatenoud L, Levi F, Praud D,
Ferlay J, Negri E, Malvezzi M and La Vecchia C: Recent patterns in
gastric cancer: A global overview. Int J Cancer. 125:666–673. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen WQ, Zheng RS, Zhang SW, Zeng HM and
Zou XN: The incidences and mortalities of major cancers in China,
2010. Chin J Cancer. 33:402–405. 2014.PubMed/NCBI
|
|
4
|
Ferlay J, Soerjomataram I, Ervik M,
Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D and
Bray F: GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality
Worldwide: IARC CancerBase No. 11 (Internet)International Agency
for Research on Cancer. Lyon, France: 2013 http://globocan.iarc.frAccessed. July
26–2015
|
|
5
|
Liu W, Yang Q, Liu B and Zhu Z: Serum
proteomics for gastric cancer. Clin Chim Acta. 431:179–184. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Röcken C: Ways to personalized medicine
for gastric cancer. Pathologe. 34:403–412. 2013.(In German).
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Humphries JM, Penno MA, Weiland F,
Klingler-Hoffmann M, Zuber A, Boussioutas A, Ernst M and Hoffmann
P: Identification and validation of novel candidate protein
biomarkers for the detection of human gastric cancer. Biochim
Biophys Acta. 1844:1051–1058. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wadhwa R, Song S, Lee JS, Yao Y, Wei Q and
Ajani JA: Gastric cancer-molecular and clinical dimensions. Nat Rev
Clin Oncol. 10:643–655. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yu Z, Pestell TG, Lisanti MP and Pestell
RG: Cancer stem cells. Int J Biochem Cell Biol. 44:2144–2151. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Okano H, Kawahara H, Toriya M, Nakao K,
Shibata S and Imai T: Function of RNA-binding protein Musashi-1 in
stem cells. Exp Cell Res. 306:349–356. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
MacNicol MC, Cragle CE and MacNicol AM:
Context-dependent regulation of Musashi-mediated mRNA translation
and cell cycle regulation. Cell Cycle. 10:39–44. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Siddall NA, McLaughlin EA, Marriner NL and
Hime GR: The RNA-binding protein Musashi is required intrinsically
to maintain stem cell identity. Proc Natl Acad Sci USA.
103:8402–8407. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Song X, Zhou C, Zhou S, Zhang L, Feng G,
Zhao D and Huang F: The expression patterns of Msi1 related with
the glioma grade and the cytoplasmic Msi1 promotes angiogenesis.
Tissue Cell. 45:1–6. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bobryshev YV, Freeman AK, Botelho NK, Tran
D, Levert-Mignon AJ and Lord RV: Expression of the putative stem
cell marker Musashi-1 in Barrett's esophagus and esophageal
adenocarcinoma. Dis Esophagus. 23:580–589. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Fan LF, Dong WG, Jiang CQ, Xia D, Liao F
and Yu QF: Expression of putative stem cell genes Musashi-1 and
beta1-integrin in human colorectal adenomas and adenocarcinomas.
Int J Colorectal Dis. 25:17–23. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li D, Peng X, Yan D, Tang H, Huang F, Yang
Y and Peng Z: Msi-1 is a predictor of survival and a novel
therapeutic target in colon cancer. Ann Surg Oncol. 18:2074–2083.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liu DC, Yang ZL and Jiang S:
Identification of musashi-1 and ALDH1 as carcinogenesis,
progression, and poor-prognosis related biomarkers for gallbladder
adenocarcinoma. Cancer Biomark. 8:113–121. 2010.-2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Götte M, Wolf M, Staebler A, Buchweitz O,
Kelsch R, Schüring AN and Kiesel L: Increased expression of the
adult stem cell marker Musashi-1 in endometriosis and endometrial
carcinoma. J Pathol. 215:317–329. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang Y, Jiang CQ and Fan LF: Correlation
of Musashi-1, Lgr5, and pEGFR expressions in human small intestinal
adenocarcinomas. Tumour Biol. 36:6075–6082. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang XY, Penalva LO, Yuan H, Linnoila RI,
Lu J, Okano H and Glazer RI: Musashi1 regulates breast tumor cell
proliferation and is a prognostic indicator of poor survival. Mol
Cancer. 9:2212010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen PX, Li QY and Yang Z: Musashi-1
expression is a prognostic factor in ovarian adenocarcinoma and
correlates with ALDH-1 expression. Pathol Oncol Res. 21:1133–1140.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ravindran G and Devaraj H: Prognostic
significance of neural stem cell markers, Nestin and Musashi-1, in
oral squamous cell carcinoma: Expression pattern of Nestin in the
precancerous stages of oral squamous epithelium. Clin Oral
Investig. 19:1251–1260. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kayahara T, Sawada M, Takaishi S, Fukui H,
Seno H, Fukuzawa H, Suzuki K, Hiai H, Kageyama R, Okano H and Chiba
T: Candidate markers for stem and early progenitor cells, Musashi-1
and Hes1, are expressed in crypt base columnar cells of mouse small
intestine. FEBS Lett. 535:131–135. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kuang RG, Kuang Y, Luo QF, Zhou CJ, Ji R
and Wang JW: Expression and significance of Musashi-1 in gastric
cancer and precancerous lesions. World J Gastroenterol.
19:6637–6644. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang T, Ong CW, Shi J, Srivastava S, Yan
B, Cheng CL, Yong WP, Chan SL, Yeoh KG, Iacopetta B and
Salto-Tellez M: Sequential expression of putative stem cell markers
in gastric carcinogenesis. Br J Cancer. 105:658–665. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Akasaka Y, Saikawa Y, Fujita K, Kubota T,
Ishikawa Y, Fujimoto A, Ishii T, Okano H and Kitajima M: Expression
of a candidate marker for progenitor cells, Musashi-1, in the
proliferative regions of human antrum and its decreased expression
in intestinal metaplasia. Histopathology. 47:348–356. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lauren P: The two histological main types
of gastric cancer: Diffuse and so-called intestinal type carcinoma.
An attempt at a histo-clinical classification. Acta Pathol
Microbiol Scand. 64:31–49. 1965.PubMed/NCBI
|
|
28
|
Bosman FT, Carneiro F, Hruban RH and
Theise ND: WHO Classification of Tumours of the Digestive System.
3. 4th. IARC Press; Lyon: 2010
|
|
29
|
Sobin L, Gospodarowicz M and Wittekind C:
TNM Classification of Malignant Tumours. 7th. International Union
Against Cancer; New York, NY: 2009
|
|
30
|
Shou ZX, Jin X and Zhao ZS: Upregulated
expression of ADAM17 is a prognostic marker for patients with
gastric cancer. Ann Surg. 256:1014–1022. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Nagata H, Akiba Y, Suzuki H, Okano H and
Hibi T: Expression of Musashi-1 in the rat stomach and changes
during mucosal injury and restitution. FEBS Lett. 580:27–33. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Murata H, Tsuji S, Tsujii M, Nakamura T,
Fu HY, Eguchi H, Asahi K, Okano H, Kawano S and Hayashi N:
Helicobacter pylori infection induces candidate stem cell marker
Musashi-1 in the human gastric epithelium. Dig Dis Sci. 53:363–369.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Choi JE, Bae JS, Lee JH, Jang KY, Chung MJ
and Moon WS: Musashi-1 expression and clinicopathological
significance in young gastric cancer patients: A matched
case-control study. Int J Oncol. 44:1185–1192. 2014.PubMed/NCBI
|
|
34
|
Vo DT, Qiao M, Smith AD, Burns SC, Brenner
AJ and Penalva LO: The oncogenic RNA-binding protein Musashi1 is
regulated by tumor suppressor miRNAs. RNA Biol. 8:817–828. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Okano H, Imai T and Okabe M: Musashi: A
translational regulator of cell fate. J Cell Sci. 115:1355–1359.
2002.PubMed/NCBI
|
|
36
|
Imai T, Tokunaga A, Yoshida T, Hashimoto
M, Mikoshiba K, Weinmaster G, Nakafuku M and Okano H: The neural
RNA-binding protein Musashi1 translationally regulates mammalian
numb gene expression by interacting with its mRNA. Mol Cell Biol.
21:3888–3900. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Fender AW, Nutter JM, Bertrand FE and
Sigounas G: Notch-1 promotes stemness and epithelial to mesenchymal
transition in colorectal cancer. J Cell Biochem. 116:2517–2527.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Abravanel DL, Belka GK, Pan TC, Pant DK,
Collins MA, Sterner CJ and Chodosh LA: Notch promotes recurrence of
dormant tumor cells following HER2/neu-targeted therapy. J Clin
Invest. 125:2484–2496. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yen WC, Fischer MM, Axelrod F, Bond C,
Cain J, Cancilla B, Henner WR, Meisner R, Sato A, Shah J, et al:
Targeting notch signaling with a notch2/notch3 antagonist
(tarextumab) inhibits tumor growth and decreases tumor-initiating
cell frequency. Clin Cancer Res. 21:2084–2095. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yuan X, Wu H, Xu H, Han N, Chu Q, Yu S,
Chen Y and Wu K: Meta-analysis reveals the correlation of Notch
signaling with non-small cell lung cancer progression and
prognosis. Sci Rep. 5:103382015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Chen W, Cao G, Yuan X, Zhang X, Zhang Q,
Zhu Y, Dong Z and Zhang S: Notch-1 knockdown suppresses
proliferation, migration and metastasis of salivary adenoid cystic
carcinoma cells. J Transl Med. 13:1672015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Nishimoto Y and Okano H: New insight into
cancer therapeutics: Induction of differentiation by regulating the
Musashi/Numb/Notch pathway. Cell Res. 20:1083–1085. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Battelli C, Nikopoulos GN, Mitchell JG and
Verdi JM: The RNA-binding protein Musashi-1 regulates neural
development through the translational repression of p21WAF-1. Mol
Cell Neurosci. 31:85–96. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Götte M, Greve B, Kelsch R, Müller-Uthoff
H, Weiss K, Masouleh Kharabi B, Sibrowski W, Kiesel L and Buchweitz
O: The adult stem cell marker Musashi-1 modulates endometrial
carcinoma cell cycle progression and apoptosis via Notch-1 and
p21WAF1/CIP1. Int J Cancer. 129:2042–2049. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Muto J, Imai T, Ogawa D, Nishimoto Y,
Okada Y, Mabuchi Y, Kawase T, Iwanami A, Mischel PS, Saya H, et al:
RNA-binding protein Musashi1 modulates glioma cell growth through
the post-transcriptional regulation of Notch and PI3 kinase/Akt
signaling pathways. PLoS One. 7:e334312012. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Chen K, Gao Q, Zhang W, Liu Z, Cai J, Liu
Y, Xu J, Li J, Yang Y and Xu X: Musashi1 regulates survival of
hepatoma cell lines by activation of Wnt signalling pathway. Liver
Int. 35:986–998. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Smith AR, Marquez RT, Tsao WC, Pathak S,
Roy A, Ping J, Wilkerson B, Lan L, Meng W, Neufeld KL, et al: Tumor
suppressive microRNA-137 negatively regulates Musashi-1 and
colorectal cancer progression. Oncotarget. 6:12558–12573. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Vo DT, Abdelmohsen K, Martindale JL, Qiao
M, Tominaga K, Burton TL, Gelfond JA, Brenner AJ, Patel V, Trageser
D, et al: The oncogenic RNA-binding protein Musashi1 is regulated
by HuR via mRNA translation and stability in glioblastoma cells.
Mol Cancer Res. 10:143–155. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Wang XY, Yu H, Linnoila RI, Li L, Li D, Mo
B, Okano H, Penalva LO and Glazer RI: Musashi1 as a potential
therapeutic target and diagnostic marker for lung cancer.
Oncotarget. 4:739–750. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Rezza A, Skah S, Roche C, Nadjar J,
Samarut J and Plateroti M: The overexpression of the putative gut
stem cell marker Musashi-1 induces tumorigenesis through Wnt and
Notch activation. J Cell Sci. 123:3256–3265. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Sureban SM, May R, George RJ, Dieckgraefe
BK, McLeod HL, Ramalingam S, Bishnupuri KS, Natarajan G, Anant S
and Houchen CW: Knockdown of RNA binding protein musashi-1 leads to
tumor regression in vivo. Gastroenterology. 134:1448–1458. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Lan L, Appelman C, Smith AR, Yu J, Larsen
S, Marquez RT, Liu H, Wu X, Gao P, Roy A, et al: Natural product
(−)-gossypol inhibits colon cancer cell growth by targeting
RNA-binding protein Musashi-1. Mol Oncol. 9:1406–1420. 2015.
View Article : Google Scholar : PubMed/NCBI
|
